Cargando…
PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428960/ http://dx.doi.org/10.1097/01.HS9.0000851216.47783.78 |
| _version_ | 1784779282977914880 |
|---|---|
| author | Soussain, C. Grommes, C. Ward, R. Peterson, C. Cravets, M. Mathias, A. Sosa, J. Kirby, B. Ding, Z. Yusuf, I. Rose, M. Steinberg, M. Tun, H. |
| author_facet | Soussain, C. Grommes, C. Ward, R. Peterson, C. Cravets, M. Mathias, A. Sosa, J. Kirby, B. Ding, Z. Yusuf, I. Rose, M. Steinberg, M. Tun, H. |
| author_sort | Soussain, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9428960 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94289602022-08-31 PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA Soussain, C. Grommes, C. Ward, R. Peterson, C. Cravets, M. Mathias, A. Sosa, J. Kirby, B. Ding, Z. Yusuf, I. Rose, M. Steinberg, M. Tun, H. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428960/ http://dx.doi.org/10.1097/01.HS9.0000851216.47783.78 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Soussain, C. Grommes, C. Ward, R. Peterson, C. Cravets, M. Mathias, A. Sosa, J. Kirby, B. Ding, Z. Yusuf, I. Rose, M. Steinberg, M. Tun, H. PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA |
| title | PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA |
| title_full | PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA |
| title_fullStr | PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA |
| title_full_unstemmed | PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA |
| title_short | PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA |
| title_sort | pb2096: a phase 1b/2 study of gb5121, a novel, highly selective, potent, and cns-penetrant btk inhibitor for relapsed/refractory primary/secondary cns lymphoma and primary vitreoretinal lymphoma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428960/ http://dx.doi.org/10.1097/01.HS9.0000851216.47783.78 |
| work_keys_str_mv | AT soussainc pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT grommesc pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT wardr pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT petersonc pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT cravetsm pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT mathiasa pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT sosaj pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT kirbyb pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT dingz pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT yusufi pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT rosem pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT steinbergm pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma AT tunh pb2096aphase1b2studyofgb5121anovelhighlyselectivepotentandcnspenetrantbtkinhibitorforrelapsedrefractoryprimarysecondarycnslymphomaandprimaryvitreoretinallymphoma |